Tag: HSBC
Product wrap: HSBC rolls out new MSCI ESG play in China
International | Products
31 Mar 2023 by Summer Wang
In this week’s wrap we look at a selection of structured products with strike dates between 27 to 31 March 2023.
HSBC launches new AI custom play in Asia
Asia Pacific | Products
30 Mar 2023 by Summer Wang
The UK bank has introduced principal-protected participation notes linked to a new artificial intelligence (AI)-driven multi-asset index in Asia, as the latest addition to its AI-powered index shelf.
Product wrap: Morgan Stanley starts Ethna revival in France
Europe | Products
24 Mar 2023 by Marc Wolterink
In this week’s wrap we look at a selection of structured products with strike dates between 19-25 March 2023.
Product wrap: French private bank tracks Euronext social focus index
International | Products
17 Mar 2023 by Marc Wolterink
In this week’s wrap we look at a selection of structured products with strike dates between 12-18 March 2023.
SRP in brief: flurry of activity
International | Industry
06 Mar 2023 by Amélie Labbe
This week is SRP Europe 2023 week! Keep an eye out for panel coverage and award winners on Thursday. Our Personality of the Year award winner will be announced tomorrow.
Product wrap: Goldman targets SX5E outperformance in France
International | Products
03 Mar 2023 by Marc Wolterink
In this week’s wrap we look at a selection of structured products with strike dates between 26 February and 4 March 2023.
HSBC net profit rises, structured notes balance up 32.4%
International | Industry
28 Feb 2023 by Summer Wang
The UK bank has reported a profit growth across three main segments in 2022 with the outstanding balance of structured notes going up by 32.4% at year-end.
Taiwan Market Review, January 2023: DBS tops the manufacturer table
Asia Pacific | Market Reviews
28 Feb 2023 by Vanina Kopcheva
Some 704 products with estimated sales of TWD67,941m ($2.2 billion) were released in January.
SRP in brief: getting a boost
International | Industry
20 Feb 2023 by Amélie Labbe
In this week’s In Brief, SRP looked at the performance of the US and French markets in 2022, and focused on how CME Group is positioned to benefit from growth in exchange-traded alternatives to OTC derivatives.